How Minnesota wolf hunter and trapper attitudes and risk- and benefit-based beliefs predict wolf management preferences

2018 ◽  
Vol 23 (6) ◽  
pp. 552-568 ◽  
Author(s):  
Susan A. Schroeder ◽  
David C. Fulton ◽  
Louis Cornicelli ◽  
Jeremy T. Bruskotter
2014 ◽  
Vol 41 (4) ◽  
pp. 303-310 ◽  
Author(s):  
CARLY C. SPONARSKI ◽  
JERRY J. VASKE ◽  
ALISTAIR J BATH ◽  
MARCO M. MUSIANI

SUMMARYShared values, public trust in an agency, and attitudes can influence support for successful conservation initiatives. To understand these relationships, this paper examines the role of social trust as a partial mediator between salient values similarity and attitudes toward wolves in south-western Alberta, Canada. Rural residents in this area face increasing wolf depredation on livestock. Data were obtained from a mail questionnaire (n= 566 respondents, response rate = 70%) sent to rural residents in three municipal districts in south-western Alberta. Attitudes were predicted to directly influence behavioural intention to support or oppose wolf management. Most respondents held slightly similar values as the management agency and minimally trusted the agency to effectively manage wolves. As predicted, social trust in the agency served as a partial mediator between salient value similarity and attitudes toward wolves. Salient value similarity was also a strong predictor of attitudes toward wolves. Attitudes toward wolves predicted behavioural support. Thus, social trust of the management agency can influence attitudes and management preferences concerning a species. When dealing with human-wildlife conflict, social trust should be examined to understand the context of the problem.


2018 ◽  
Vol 82 (4) ◽  
pp. 711-722 ◽  
Author(s):  
Nicholas. J. DeCesare ◽  
Seth M. Wilson ◽  
Elizabeth H. Bradley ◽  
Justin A. Gude ◽  
Robert M. Inman ◽  
...  
Keyword(s):  

2015 ◽  
Vol 21 (2) ◽  
pp. 117-129 ◽  
Author(s):  
Constantinos Hadjichristidis ◽  
Janet Geipel ◽  
Lucia Savadori

1993 ◽  
Vol 101 ◽  
pp. 291 ◽  
Author(s):  
C. S. Aaron ◽  
P. R. Harbach ◽  
S. S. Mattano ◽  
J. K. Mayo ◽  
Y. Wang ◽  
...  

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Xiang Yu ◽  
Jingjiang Pan ◽  
Xiaoying Zhao ◽  
Xianfeng Yu ◽  
Bin Liu

2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
Jun Young Lee ◽  
Jae Won Yang ◽  
Jae Seok Kim ◽  
Seong Ok Choi ◽  
Byoung Geun Han

Abstract Background and Aims Atrial fibrillation (AF) is common arrhythmia in end stage renal disease patients. Although, the need of anticoagulation to prevent stroke and thromboembolism is increasing, the efficacy of anticoagulation is not proven in most of study. We retrospectively analyzed the risk and benefit of anticoagulation in dialysis patients with AF. Method By using medical record, we retrospectively analyzed all data of 99 patients who received dialysis therapy and diagnosed AF. Results Among 99 patients who diagnosed AF with dialysis 36 patients received anticoagulation (17 coumadin, 19 apixaban 2.5mg bid), 63 patients received no anticoagulation. There was no significant difference of baseline characteristics between anticoagulation, and no anticoagulation patients. Although no anticoagulation group experienced more all-cause (39.7% vs 32.4%, p=0.572) and cardiovascular mortality (17.6% vs 10.8%, p=0.197) than anticoagulation group it was not statistically significant. Compared to apixaban 2.5mg bid patients, coumadin anticoagulation patients experienced more frequent mfig ajor adverse cardiovascular events (35.3% vs 15.8%, p=0.109) but it was not statistically significant in multi variate Cox regression analysis (Hazard ratio 1.143, 95% Confidence Interval 0.503-2.597). Conclusion Apixaban 2.5mg bid was not inferior than coumadin considering risk and benefit of anticoagulation in dialysis patients.


2021 ◽  
pp. bmjebm-2021-111773
Author(s):  
David Robert Grimes

Vaccination is a life-saving endeavour, yet risk and uncertainty are unavoidable in science and medicine. Vaccination remains contentious in the public mind, and vaccine hesitancy is a serious public health issue. This has recently been reignited in the discussion over potential side effects of COVID-19 vaccines, and the decision by several countries to suspend measures such as the AstraZeneca vaccine. In these instances, the precautionary principle has often been invoked as a rationale, yet such heuristics do not adequately weigh potential harms against real benefits. How we analyse, communicate and react to potential harms is absolutely paramount to ensure the best decisions and outcomes for societal health, and maintaining public confidence. While balancing benefits and risks is an essential undertaking, it cannot be achieved without due consideration of several other pertinent factors, especially in the context of vaccination, where misguided or exaggerated fears have in the past imperilled public health. While well meaning, over reactions to potential hazards of vaccination and other health interventions can have unintended consequences, and cause lingering damage to public trust. In this analysis, we explore the challenges of assessing risk and benefit, and the limitations of the precautionary principle in these endeavours. When risk is unclear, cautious vigilance might be a more pragmatic and useful policy than reactionary suspensions.


Sign in / Sign up

Export Citation Format

Share Document